Dr. Alberto Dávalos holds a degree in Pharmacy and Biochemistry by San Marcos University (Lima) and a PhD in Pharmacy by Universidad Complutense de Madrid (Madrid). He has conducted postdoctoral research at the Hospital Ramón y Cajal (Madrid), at Yale University School of Medicine, (New Haven), and at New York University School of Medicine (New York). Dr. Dávalos’s research program focuses in identifying and characterizing new noncoding RNAs (miRNAs, lncRNAs and other type of regulatory RNAs) that regulate lipid metabolism and the effects of minor dietary components (micronutrients) on their expression.
Dr. Dávalos has developed an active research program in the last 10 years leading the “Laboratory of Epigenetics of Lipid Metabolism” at IMDEA Food Institute (Madrid).
His major scientific contributions can be summarized in five topics.
I) The role of microRNAs in lipid metabolism.
II) The regulation of tissue miRNAs and DNA methylation by both dietary components and diet
III) The regulation of circulating miRNAs by physical activity and the use of circulating miRNAs as biomarkers of disease.
IV) The regulation of circulating miRNAs by physical activity and the use of circulating miRNAs as biomarkers of disease.
V) The use of extracellular vesicles (EVs) for miRNA-based therapy and dietary exogenous miRNAs
The following scientific-related indicators from his research career includes (Scopus): h-index 46; total cites 9946, per year around 900 (in the last 5 y); 138 JCR peer-reviewed articles (52, last 5 y); total publications in first quartile (Q1) 95%, in first decile (D1): 20%.